Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice
Open accessAbstract
Legumain-based DNA vaccines have potential to protect against breast cancer. However, the lack of a safe and efficient oral delivery system restricts its clinical application. Here, we constructed alginic acid-coated chitosan nanoparticles (A.C.NPs) as an oral delivery carrier for a legumain DNA vaccine. First, we tested its characteristic in acidic environments in vitro. DNA agarose electrophoresis data show that A.C.NPs protected DNA better from degradation in acidic solution (pH 1.5) than did chitosan nanoparticles (C.NPs). Furthermore, size distribution analysis showed that A.C.NPs tended to aggregate and form micrometer scale complexes in pH<2.7, while dispersing into nanoparticles with an increase in pH. Mice were intragastrically administrated A.C.NPs carrying EGFP plasmids and EGFP expression was detected in the intestinal Peyer's patches. Full-length legumain plasmids were loaded into different delivery carriers, including C.NPs, attenuated Salmonella typhimurium and A.C.NPs. A.C.NPs loaded with empty plasmids served as a control. Oral vaccination was performed in the murine orthotopic 4T1 breast cancer model. Our data indicate that tumor volume was significantly smaller in groups using A.C.NPs or attenuated Salmonella typhimurium as carriers. Furthermore, splenocytes co-cultured them with 4T1 cells pre-stimulated with CoCl2, which influenced the translocation of legumain from cytoplasm to plasma membrane, showed a 4.7 and 2.3 folds increase in active cytotoxic T lymphocytes (CD3(+)/CD8(+)/CD25(+)) when treated with A.C.NPs carriers compared with PBS C.NPs. Our study suggests that C.NPs coated with alginic acid may be a safe and efficient tool for oral delivery of a DNA vaccine. Moreover, a legumain DNA vaccine delivered orally with A.C.NPs can effectively improve autoimmune response and protect against breast cancer in mice.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This vaccine could effectively improve autoimmune response and protect against breast cancer in mice.
“It was shown that this vaccine could effectively improve autoimmune response and protect against breast cancer in mice [91].”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [91]
Alginic acid-coated chitosan nanoparticles have been constructed as an oral delivery carrier for legumain-based DNA vaccine.
“Alginic acid-coated chitosan nanoparticles have been constructed as an oral delivery carrier for the legumain-based DNA vaccine.”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [91]
Polysaccharides isolated from various microalgae ranging from diatoms to green-blue algae demonstrated different activities, although direct anticancer properties were rarely reported.
“Polysaccharides isolated from various microalgae ranging from diatoms to green-blue algae demonstrated different activities, although direct anticancer properties were rarely reported [91].”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
Implantable applications of chitin and chitosan
Khor, E., & Lim, L. Y. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00026-7 · Cited by 1,672 · see citing works
Roy, K., Mao, H., Huang, S. K., & Leong, K. W. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,106 · see citing works
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823 · see citing works
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W., Huang, Y., Roberts, A., Murphy, B., Subbarao, K., & Nabel, G. (2004) · Nature · doi:10.1038/nature02463 · Cited by 688 · see citing works
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Luo, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27648 · Cited by 554 · see citing works
Yin, L., Ding, J., He, C., Cui, L., Tang, C., & Yin, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.055 · Cited by 449 · see citing works
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439 · see citing works
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
Niethammer, A. G., Xiang, R., Becker, J. C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B. P., & Reisfeld, R. A. (2002) · Nature Medicine · doi:10.1038/nm1202-794 · Cited by 400 · see citing works
Self-citationFourcade, J., Sun, Z., Pagliano, O., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Olive, D., Kuchroo, V., & Zarour, H. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2637 · Cited by 372 · see citing works
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines
Wang, C., Ge, Q., Ting, D. T., Nguyen, D. N., Shen, H.-R., Chen, J., Eisen, H. N., Heller, J., Langer, R., & Putnam, D. A. (2004) · Nature Materials · doi:10.1038/nmat1075 · Cited by 263 · see citing works
Boyle, J. S., Brady, J. L., & Lew, A. M. (1998) · Nature · doi:10.1038/32932 · Cited by 244 · see citing works
Holmgren, J. R., Adamsson, J., Anjuère, F., Clemens, J. D., Czerkinsky, C. C., Eriksson, K., Flach, C., George‐Chandy, A., Harandi, A. M., Lebens, M., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.11.009 · Cited by 228 · see citing works
Lee, S. J., Koo, H., Jeong, H., Huh, M. S., Choi, Y., Jeong, S. Y., Byun, Y., Choi, K., Kim, K., & Kwon, I. C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.027 · Cited by 217 · see citing works
Schmidt, G. H. (1985) · Cell · doi:10.1016/0092-8674(85)90156-4 · Cited by 187 · see citing works
Sonaje, K., Lin, K., Wey, S., Lin, C.-K., Yeh, T.-H., Nguyen, H.-N., Hsu, C., Yen, T., Juang, J., & Sung, H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.042 · Cited by 187 · see citing works
Borges, O., Cordeiro‐da‐Silva, A., Romeijn, S. G., Amidi, M., de Sousa, A., Borchard, G., & Junginger, H. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.011 · Cited by 185 · see citing works
Poly-l-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy
Minigo, G., Scholzen, A., Tang, C. K., Hanley, J. C., Kalkanidis, M., Pietersz, G. A., Apostolopoulos, V., & Plebanski, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.086 · Cited by 151 · see citing works
Yoo, M. K., Kang, S., Choi, J.-H., Park, I., Na, H. S., Lee, H., Kim, E.-B., Lee, N.-K., Nah, J., Choi, Y.-J., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.059 · Cited by 150 · see citing works
Iqbal, M., Lin, W., Jabbal‐Gill, I., Davis, S. S., Steward, M. W., & Illum, L. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00662-x · Cited by 136 · see citing works
Zhou, X., Zhang, X., Yu, X., Zha, X., Fu, Q., Liu, B., Wang, X., Chen, Y., Chen, Y., Shan, Y., et al. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.007 · Cited by 130 · see citing works
Borges, O., Silva, M., de Sousa, A., Borchard, G., Junginger, H. E., & Cordeiro‐da‐Silva, A. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.08.013 · Cited by 109 · see citing works
Lewén, S., Zhou, H., Hu, H., Cheng, T., Markowitz, D., Reisfeld, R. A., Xiang, R., & Luo, Y. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0389-x · Cited by 95 · see citing works
Self-citationXiang, R., Luo, Y., Niethammer, A. G., & Reisfeld, R. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00613.x · Cited by 80 · see citing works
Self-citationXu, Q., Guo, L., Gu, X., Zhang, B., Hu, X., Zhang, J., Chen, J., Wang, Y., Chen, C., Gao, B., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.014 · Cited by 79 · see citing works
Doroud, D., Zahedifard, F., Vatanara, A., Najafabadi, A. R., Taslimi, Y., Vahabpour, R., Torkashvand, F., Vaziri, B., & Rafati, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.011 · Cited by 68 · see citing works
Liao, D., Liu, Z., Wrasidlo, W., Luo, Y., Nguyen, G., Chen, T., Xiang, R., & Reisfeld, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1264 · Cited by 63 · see citing works
Self-citationLiao, D., Liu, Z., Wrasidlo, W., Chen, T., Luo, Y., Xiang, R., & Reisfeld, R. A. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.03.001 · Cited by 60 · see citing works
Self-citationOral delivery of micro-encapsulated DNA vaccines.
Jones, D. H., Clegg, J. C. S., & Farrar, G. H. (1998) · PubMed · Cited by 46 · see citing works
Enhanced cell survival of melanocyte spheroids in serum starvation condition
Lin, S., Jee, S., Hsiao, W.-C., Yu, H., Tsai, T., Chen, J., Hsu, C., & Young, T. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.08.031 · Cited by 42 · see citing works
Luo, Y., Zhou, H., Mizutani, M., Mizutani, N., Liu, C., Xiang, R., & Reisfeld, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3120 · Cited by 41 · see citing works
Self-citationSalmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids
Bauer, H., Darji, A., Chakraborty, T., & Weiss, S. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302423 · Cited by 35 · see citing works
Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen
Bhowmik, T., D’Souza, B., Uddin, M. N., & D’Souza, M. J. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.662686 · Cited by 30 · see citing works
Micro- and Nanoparticle-Based Vaccines for Hepatitis B
Bharali, D. J., Mousa, S. A., & Thanavala, Y. M. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_44 · Cited by 23 · see citing works
Fu, J., Zhao, B., Dong, Z., Sun, Y., Luan, H., Shen, X., Gao, X., Gong, F., Li, S.-B., & Song, H. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.002 · Cited by 10 · see citing works
Gene Therapy for Severe Combined Immunodeficiency Disease
Handgretinger, R., Kościelniak, E., & NIETHAMMER, D. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208223470814 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [25]Borges O, Cordeiro-da-Silva A, Romeijn SG, Amidi M, de Sousa A, et al.. (2006) Uptake studies in rat Peyer’s patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Control Release 114: 348–358. Epub 2006 Jun 2016. 16905219
Cited by
Sorted by citations
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
Zhou, Z., Liu, X., Zhu, D., Wang, Y., Zhang, Z., Zhou, X., Qiu, N., Chen, X., & Shen, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.021 · Cited by 380 · see citing works
Self-citation“The Good, the Bad and the Ugly” of Chitosans
Bellich, B., D’Agostino, I., Semeraro, S., Gamini, A., & Cesàro, A. (2016) · Marine Drugs · doi:10.3390/md14050099 · Cited by 377 · see citing works
Biomaterials for Nanoparticle Vaccine Delivery Systems
Sahdev, P., Ochyl, L. J., & Moon, J. J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1419-y · Cited by 308 · see citing works
Structure and function of legumain in health and disease
Dall, E., & Brandstetter, H. (2015) · Biochimie · doi:10.1016/j.biochi.2015.09.022 · Cited by 281 · see citing works
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Fan, Y., & Moon, J. J. (2015) · Vaccines · doi:10.3390/vaccines3030662 · Cited by 276 · see citing works
Siafaka, P. I., Okur, N. Ü., Karavas, E., & Bikiaris, D. Ν. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091440 · Cited by 224 · see citing works
Tumor-Associated Macrophages as Target for Antitumor Therapy
Sawa-Wejksza, K., & Kandefer‐Szerszeń, M. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0480-8 · Cited by 199 · see citing works
Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects
Fedorov, S., Ermakova, S., Zvyagintseva, T., & Stonik, V. (2013) · Marine Drugs · doi:10.3390/md11124876 · Cited by 189 · see citing works
Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
Liu, Z., Xiong, M., Gong, J., Zhang, Y., Bai, N., Luo, Y., Li, L., Wei, Y., Liu, Y., Tan, X., et al. (2014) · Nature Communications · doi:10.1038/ncomms5280 · Cited by 184 · see citing works
Self-citationWang, X., Chen, Y., Dahmani, F. Z., Yin, L., Zhou, J., & Yao, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.053 · Cited by 162 · see citing works
Oral delivery of nanoparticle-based vaccines
Marasini, N., Skwarczyński, M., & Tóth, I. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.936852 · Cited by 157 · see citing works
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy
Babu, A., & Ramesh, R. (2017) · Marine Drugs · doi:10.3390/md15040096 · Cited by 150 · see citing works
Biomedical Nanoparticles: Overview of Their Surface Immune-Compatibility
Gamucci, O., Bertero, A., Gagliardi, M., & Bardi, G. (2014) · Coatings · doi:10.3390/coatings4010139 · Cited by 132 · see citing works
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Cuzzubbo, S., Mangsbo, S. M., Nagarajan, D., Habra, K., Pockley, A. G., & McArdle, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615240 · Cited by 130 · see citing works
Theranostic nanoparticles with disease-specific administration strategies
Zhang, P., Li, Y., Tang, W., Zhao, J., Jing, L., & McHugh, K. J. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101335 · Cited by 118 · see citing works
Biswas, S., Chattopadhyay, M., Sen, K. K., & Saha, M. K. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.044 · Cited by 109 · see citing works
How successful is nuclear targeting by nanocarriers?
Tammam, S. N., Azzazy, H. M. E.-S., & Lamprecht, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.022 · Cited by 108 · see citing works
Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
Jazayeri, S. D., Lim, H. X., Shameli, K., Yeap, S. K., & Poh, C. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.682286 · Cited by 100 · see citing works
Chemical Modification of Chitosan for Efficient Vaccine Delivery
Xing, L., Fan, Y., Zhou, T., Gong, J., Cui, L.-H., Cho, K., Choi, Y., Jiang, H., & Cho, C. (2018) · Molecules · doi:10.3390/molecules23020229 · Cited by 94 · see citing works
Self-citationPathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
Rosenthal, J. A., Chen, L., Baker, J. L., Putnam, D. A., & DeLisa, M. P. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.11.005 · Cited by 92 · see citing works
Polymer nanotechnology based approaches in mucosal vaccine delivery: Challenges and opportunities
Sharma, R. K., Agrawal, U., Mody, N., & Vyas, S. P. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.12.004 · Cited by 91 · see citing works
Micro- and nanoparticulates for DNA vaccine delivery
Farris, E., Brown, D. M., Ramer‐Tait, A. E., & Pannier, A. K. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216643771 · Cited by 86 · see citing works
Song, X., Wan, Z., Chen, T., Fu, Y. S., Jiang, K., Yi, X., Ke, H., Dong, J., Yang, L., Li, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.001 · Cited by 82 · see citing works
Natural and semisynthetic polymers in pharmaceutical nanotechnology
Dmour, I. M., & Taha, M. O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813663-8.00002-6 · Cited by 78 · see citing works
Chitosan: A versatile bio-platform for breast cancer theranostics
Madamsetty, V. S., Tavakol, S., Moghassemi, S., Dadashzadeh, A., Schneible, J. D., Fatemi, I., Shirvani, A., Zarrabi, A., Azedi, F., Dehshahri, A., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.012 · Cited by 74 · see citing works
Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
Davodabadi, F., Sarhadi, M., Arabpour, J., Sargazi, S., Rahdar, A., & Diez-Pascual, A. M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.036 · Cited by 73 · see citing works
Insulin-loaded alginic acid nanoparticles for sublingual delivery
Patil, N. H., & Devarajan, P. V. (2014) · Drug Delivery · doi:10.3109/10717544.2014.916769 · Cited by 73 · see citing works
Zhen, Y., Guo, C., Wenzhi, S., Zhao, S., Luo, N., Rongrong, W., Luo, X., Niu, H., Dehong, L., Shan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep16599 · Cited by 72 · see citing works
Self-citationEngineered polysaccharides for controlling innate and adaptive immune responses
Nam, J., Kim, A., Kim, K. H., Moon, J. H., Baig, J., Phoo, M. T., Moon, J. J., & Son, S. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00193-2 · Cited by 69 · see citing works
Rafiee, A., Alimohammadian, M. H., Gazori, T., Riazi‐Rad, F., Fatemi, S. M. R., Parizadeh, A., Haririan, I., & Havaskary, M. (2014) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(14)60590-9 · Cited by 68 · see citing works
Biopolymer‐based Carriers for DNA Vaccine Design
Franck, C. O., Fanslau, L., Bistrović, A., Tyagi, P., & Fruk, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010282 · Cited by 62 · see citing works
Polymers for DNA Vaccine Delivery
Zhang, M., Hong, Y., Chen, W., & Wang, C. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00418 · Cited by 60 · see citing works
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Dosekova, E., Filip, J., Bertók, T., Both, P., Kasák, P., & Tkáč, J. (2016) · Medicinal Research Reviews · doi:10.1002/med.21420 · Cited by 60 · see citing works
Chellappan, D. K., Yee, N. J., Singh, B. J. A. J., Panneerselvam, J., Madheswaran, T., Chellian, J., Satija, S., Mehta, M., Gulati, M., Gupta, G., et al. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0019 · Cited by 54 · see citing works
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Chen, Z., Yue, Z., Yang, K., Shen, C., Cheng, Z., Zhou, X., & Li, S. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300882 · Cited by 52 · see citing works
Lima, B. V., Oliveira, M. J., Barbosa, M. A., Gonçalves, R. M., & Castro, F. (2021) · Biomaterials Science · doi:10.1039/d0bm01984d · Cited by 51 · see citing works
Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
Caprifico, A. E., Foot, P. J. S., Polycarpou, E., & Calabrese, G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091840 · Cited by 50 · see citing works
Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines
Ferber, S., Gonzalez, R. J., Cryer, A. M., von Andrian, U. H., & Artzi, N. (2019) · Advanced Materials · doi:10.1002/adma.201903847 · Cited by 49 · see citing works
An Overview of Nanomaterial Applications in Pharmacology
Roy, M., Roy, A., Rustagi, S., & Pandey, N. (2023) · BioMed Research International · doi:10.1155/2023/4838043 · Cited by 48 · see citing works
Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
Chuang, S. T., Conklin, B., Stein, J. B., Pan, G., & Lee, K. (2022) · Nano Convergence · doi:10.1186/s40580-022-00310-0 · Cited by 48 · see citing works
Plausible role of chitosan in drug and gene delivery against resistant breast cancer cells
Nandgude, T. D., & Pagar, R. R. (2021) · Carbohydrate Research · doi:10.1016/j.carres.2021.108357 · Cited by 47 · see citing works
Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
Khan, S. U., Khan, I. M., Khan, M. U., Din, M. A. U., Khan, M. Z., Khan, N. M., & Liu, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1121964 · Cited by 46 · see citing works
Lybaert, L., Vermaelen, K. Y., Geest, B. G. D., & Nuhn, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.009 · Cited by 46 · see citing works
Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model
Zhang, W., Pan, Y., Gou, P., Zhou, C., Ma, L., Liu, Q., Du, Y., Yang, J., & Wang, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.6094 · Cited by 44 · see citing works
Cancer immunotherapy: a promising dawn in cancer research.
Bondhopadhyay, B., Sisodiya, S., Chikara, A., Khan, A., Tanwar, P., Afroze, D., Singh, N., Agrawal, U., Mehrotra, R., & Hussain, S. (2020) · Europe PMC (PubMed Central) · Cited by 41 · see citing works
Yu, Z., Zhang, X., Pei, X., Cao, W., Ye, J., Wang, J., Sun, L., Yu, F., Wang, J., Li, N., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120940 · Cited by 40 · see citing works
Kaikabo, A. A., Mohammed, A. S., & Abas, F. (2016) · Molecules · doi:10.3390/molecules21030256 · Cited by 37 · see citing works
Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
Koyande, N. P., Srivastava, R., Padmakumar, A., & Rengan, A. K. (2022) · Vaccines · doi:10.3390/vaccines10101727 · Cited by 31 · see citing works
Non-invasive administration of biodegradable nano-carrier vaccines.
Kalam, M. A., Khan, A. A., & Alshamsan, A. (2017) · PubMed Central · Cited by 28 · see citing works
Recent advances in the development of breast cancer vaccines
Valabrega, G., Milani, A., Aglietta, M., & Sangiolo, D. (2014) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s38428 · Cited by 27 · see citing works
Alginate Containing Nanoarchitectonics for Improved Cancer Therapy
Giri, T. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47347-7.00020-3 · Cited by 26 · see citing works
Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
Allahverdiyev, A., Tari, G., Bağırova, M., & Abamor, E. Ş. (2018) · Journal of Breast Cancer · doi:10.4048/jbc.2018.21.e47 · Cited by 25 · see citing works
Chitosan nano-formulation enhances stability and bactericidal activity of the lytic phage HK6
Temsaah, H. R., Abdelkader, K., Ahmed, A. E., Elgiddawy, N., Eldin, Z. E., Elshebrawy, H. A., Kasem, N. G., El-Gohary, F. A., & Azmy, A. F. (2025) · BMC Biotechnology · doi:10.1186/s12896-024-00934-6 · Cited by 24 · see citing works
Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review
Danaeifar, M., Negahdari, B., Eslam, H. M., Zare, H., Ghanaat, M., Koushali, S. S., & Malekshahi, Z. V. (2023) · Biotechnology Letters · doi:10.1007/s10529-023-03383-x · Cited by 24 · see citing works
The Use of Immunotherapy to Treat Metastatic Breast Cancer
Nicolini, A., Barak, V., Biava, P. M., Ferrari, P., Rossi, G., & Carpi, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180209124052 · Cited by 24 · see citing works
Engineered biomaterials for development of nucleic acid vaccines
Yang, H. J., Li, Y., Jin, S., Xu, J., Wang, P. C., Liang, X., & Zhang, X. (2015) · Biomaterials Research · doi:10.1186/s40824-014-0025-8 · Cited by 23 · see citing works
Wang, M., Yue, Y., Dong, C., Li, X., Xu, W., & Xiong, S. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00466-13 · Cited by 22 · see citing works
A new tandem peptide modified liposomal doxorubicin for tumor “ecological therapy”
Zhao, T., Zhou, H., Lei, L., Guo, C., Yang, Q., Gong, T., Sun, X., Song, X., Gong, T., & Zhang, Z. (2020) · Nanoscale · doi:10.1039/c9nr09585c · Cited by 21 · see citing works
Peng, H. C., Wang, J., Guo, F., Zhu, F.-F., Wen, Z.-J., Zhong, H., & Liang, D.-S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111442 · Cited by 20 · see citing works
Bande, F., Arshad, S. S., Bejo, M. H., Kamba, A. S., & Omar, A. R. (2015) · Journal of Nanomaterials · doi:10.1155/2015/371529 · Cited by 20 · see citing works
Chen, H., Liu, X., Clayman, E. S., Shao, F., Xiao, M., Tian, X., Fu, W.-Y., Zhang, C., Ruan, B.-B., Zhou, P., et al. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12525 · Cited by 20 · see citing works
Self-citationDeniz, İ., García‐Vaquero, M., & İmamoğlu, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101023-5.00018-2 · Cited by 20 · see citing works
VLPs and particle strategies for cancer vaccines
Ungaro, F., Conte, C., Quaglia, F., Tornesello, M. L., Buonaguro, L., & Buonaguro, L. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.836909 · Cited by 18 · see citing works
Application of multifunctional nanomaterials in cancer vaccines (Review)
Fu, B., Huang, X., Deng, J., Gu, D., Mei, Q., Deng, M., Tang, S., & ⁄, M. L. (2018) · Oncology Reports · doi:10.3892/or.2018.6206 · Cited by 18 · see citing works
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
Navarro-Ocón, A., Blaya-Cánovas, J. L., López-Tejada, A., Blancas, I., Sanchez-Martin, R. M., Garrido, M. J., Griñán‐Lisón, C., Calahorra, J., Cara, F. E., Ruiz‐Cabello, F., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030505 · Cited by 17 · see citing works
Polymer-Based Nanoparticles as Modern Vaccine Delivery Systems
Lambricht, L., Peres, C. A., Florindo, H. F., Véronique Préat, A., & Vandermeulen, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39981-4.00010-5 · Cited by 16 · see citing works
Nanometric Biopolymer Devices for Oral Delivery of Macromolecules with Clinical Significance
Maiti, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00006-x · Cited by 16 · see citing works
Single-dose in situ storage for intensifying anticancer efficacy via combinatorial strategy
Hou, L., Yan, Y., Tian, C., Huang, Q., Fu, X.-J., Zhang, Z., Zhang, H., Zhang, H., & Zhang, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.014 · Cited by 16 · see citing works
Lin, S., Deng, F., Huang, P., Li, L., Wang, L., Li, Q. F., Chen, L., Chen, H., & Nan, K. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00736d · Cited by 15 · see citing works
Yazdani, M., Jaafari, M. R., Verdi, J., Alani, B., Noureddini, M., & Badiee, A. (2020) · Immunotherapy · doi:10.2217/imt-2019-0173 · Cited by 14 · see citing works
Luo, M., Li, Q., Wang, D., Ge, C., Wang, J., Nan, K., & Lin, S. (2018) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6149-y · Cited by 14 · see citing works
Self-citationPolysaccharide-Based Nanocarriers for Drug Delivery
Teijeiro, C., McGlone, A., Csaba, N., García-Fuentes, M., & Alonso, M. J. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0007 · Cited by 12 · see citing works
Therapeutic effects of chitosan in veterinary dermatology: A systematic review of the literature
Maldonado-Cabrera, B., Sánchez‐Machado, D. I., López‐Cervántes, J., Osuna-Chávez, R. F., Escárcega-Galaz, A. A., Robles‐Zepeda, R. E., & Sanches-Silva, A. T. (2021) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2021.105325 · Cited by 12 · see citing works
Chitosan Nanoparticles: An Emerging Weapon against the Cancer
Potdar, P. (2016) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2016.03.00049 · Cited by 10 · see citing works
Chitosan Nanoparticles: An Overview on Preparation, Characterization and Biomedical Applications
Mesa, A., Mythatha, G. S. S., Lodi, R. S., Ravuri, S. K., & Balli, R. (2021) · Environmental and microbial biotechnology · doi:10.1007/978-981-15-9916-3_17 · Cited by 10 · see citing works
Biopolymer‐based Carriers for DNA Vaccine Design
Franck, C. O., Fanslau, L., Bistrović, A., Tyagi, P., & Fruk, L. (2020) · Angewandte Chemie · doi:10.1002/ange.202010282 · Cited by 10 · see citing works
Martino, A. D., Özaltın, K., Trusova, M. E., Постников, П. С., & Sedlařík, V. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.01.003 · Cited by 9 · see citing works
Alginic Acid: a Potential Biopolymer from Brown Algae
(2020) · Materials International · doi:10.33263/materials23.433438 · Cited by 9 · see citing works
New Era on Combining Both Imaging and Drug Delivery to Treat Cancer
Siafaka, P. I., Çağlar, E. Ş., Gündoğdu, E., & Okur, N. Ü. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220617152334 · Cited by 8 · see citing works
An Ocean of Possibilities: A Review of Marine Organisms as Sources of Nanoparticles for Cancer Care
Püsküllüoğlu, M., & Michalak, I. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0206 · Cited by 8 · see citing works
Zhao, T., Li, Z., Guo, Z., Wang, A., Liu, Z., Zhao, Q. S., Li, Y., McKenzie, E. A., & Diao, A. (2018) · Protein Expression and Purification · doi:10.1016/j.pep.2018.05.003 · Cited by 8 · see citing works
Self-citationGovindan, P., Pitchaikani, S., Kandasamy, S., Rajan, M., Shakila, H., Eed, E. M., Elfasakhany, A., & Pugazhendhi, A. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111699 · Cited by 8 · see citing works
RetractedNanoparticle Technology for Respiratory Tract Mucosal Vaccine Delivery
Johnson, L. M., Mecham, J. B., Quinn, F. D., & Hickey, A. J. (2019) · KONA Powder and Particle Journal · doi:10.14356/kona.2020013 · Cited by 8 · see citing works
Alginate in Gene and Vaccine Delivery
Abdelhamid, H. N. (2023) · Springer eBooks · doi:10.1007/978-981-19-6937-9_14 · Cited by 7 · see citing works
Nanotechnology Approaches for Cancer Immunotherapy and Immunomodulation
de la Fuente, M., Langer, R., & Alonso, M. J. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_8 · Cited by 7 · see citing works
Extraction, structural properties, and applications of alginic acid
Hassabo, A. G., & Mohamed, A. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99468-2.00023-1 · Cited by 6 · see citing works
PRAKASH, D., Arora, V., & Dewangan, H. K. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i5.48183 · Cited by 6 · see citing works
Peyer’s Patch: Targeted Drug Delivery for Therapeutics Benefits
Patel, R. P., Shah, P., Barve, K. H., Patel, N. A., & Gandhi, J. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_5 · Cited by 6 · see citing works
Interaction of green nanoparticles with cells and organs
Rahim, M., Rizvi, S. M. D., Iram, S., Khan, S., Bagga, P., & Khan, M. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813661-4.00005-5 · Cited by 6 · see citing works
Blades and barriers: Oral vaccines for conquering cancers and warding off infectious diseases
Yang, K., Liu, J., Zhao, Y., Xu, H., Zu, M., Li, B., Shi, X., Reis, R. L., Kundu, S. C., & Xiao, B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.038 · Cited by 5 · see citing works
Das, S., Pan, R., Dey, R., & Ghosh, M. (2022) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v12i1-s.5345 · Cited by 5 · see citing works
In vitro evaluation of polyethylene glycol based microparticles containing azithromycin
Shunmugaperumal, T., Kumar, V., Sharma, D., & Thakur, A. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0187-2 · Cited by 5 · see citing works
Chitosan-Based Mucosal Nanovaccines
Rosales‐Mendoza, S., & González‐Ortega, O. (2019) · Springer eBooks · doi:10.1007/978-3-030-31668-6_8 · Cited by 5 · see citing works
Marine Algal‐derived Pharmaceuticals
Cheriyamundath, S., & Vavilala, S. L. (2020) · Wiley eBooks · doi:10.1002/9781119143802.ch120 · Cited by 5 · see citing works
Farzi, G., & Gheysipour, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824345-9.00010-6 · Cited by 4 · see citing works
Recent Trends and Strategies for Targeting M – Cells via Oral Vaccine against Hepatitis B: A Review
Saraf, S. K. (2019) · International Journal of Cell Science & Molecular Biology · doi:10.19080/ijcsmb.2019.05.555671 · Cited by 4 · see citing works
Advanced drug delivery systems in breast cancer
Singh, S., Singh, P., Mishra, N., Maurya, P., Singh, N., Nisha, R., & Saraf, S. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00028-6 · Cited by 4 · see citing works
Shunmugaperumal, T., Sharma, D., Thakur, A., & Vinaykumar (2013) · Interventional Medicine and Applied Science · doi:10.1556/imas.5.2013.4.5 · Cited by 4 · see citing works
Nanotechnology for RNA and DNA Delivery in Cancer Therapeutics
Safo, K. K., Ogoe, M., George, N., Gupta, A., Janiyani, K., Singh, H., Babu, K. G., & Pandya, S. R. (2025) · Series in bioengineering · doi:10.1007/978-981-95-0457-2_7 · Cited by 3 · see citing works
TRIVALENT ION CROSS-LINKED AND ACETALATED GELLAN GUM MICROSPHERES OF GLIMEPIRIDE
Das, S., & Dey, R. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i5.37229 · Cited by 3 · see citing works
- Authors
- Liu, Z., Lv, D., Liu, S., Gong, J., Wang, D., Xiong, M., Chen, X., Xiang, R., & Tan, X.
- Affiliations
- Nankai University (CN)
- Tianjin University (CN)
- Corresponding author
- Tan, Xiaoyue
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-05
- Volume
- 8
- Issue
- 4
- Pages
- e60190
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3618226
- OpenAlex
- W1993169857
- Cited by
- 108
- References
- 37
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 8 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 7 · 2016: 13 · 2015: 9 · 2014: 11 · 2013: 7
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (81273331, 2013CB967201, 973 Program, 81270774)
- National Key Research and Development Program of China (2013CB967201)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- legumain, DNA vaccine, breast cancer, chitosan nanoparticles, oral vaccine delivery, attenuated Salmonella typhimurium, 4T1 breast cancer, cytotoxic T lymphocytes, Peyer's patches, nanoparticle aggregation
- MeSH terms
- Asparaginyl Endopeptidase, Alginates, Animals, Antigen-Presenting Cells, Biological Transport, Cysteine Endopeptidases, Drug Carriers, Female, Gastric Mucosa, Hexuronic Acids, Hydrogen-Ion Concentration, Macrophages, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Peyer's Patches, T-Lymphocytes, Vaccines, DNA, Cancer Vaccines, Glucuronic Acid, Chitosan, Cell Proliferation, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
